Related Experiment Video
Updated: Apr 6, 2026
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Novel Therapies for Eosinophilic Disorders
1Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, 240 East Huron Street, Room M-306, Chicago, IL 60611, USA.
Current eosinophilic disorder treatments are limited and often toxic. New biologics and small molecules show promise for directly targeting eosinophils and inflammation, offering potential therapeutic advancements.
Area of Science:
- Immunology
- Pharmacology
- Allergy and Clinical Immunology
Background:
- Eosinophilic disorders lack effective, evidence-based therapies.
- Current treatments are empirical, often off-label, and rely on toxic glucocorticoids.
Purpose of the Study:
- To review the progress in developing novel therapeutics for eosinophilic disorders.
- To highlight biologics and small molecules targeting eosinophil pathways.
Main Methods:
- Review of preclinical and clinical studies.
- Analysis of therapeutic agents targeting eosinophil biology and inflammation.
Main Results:
- Significant advancements in discovering and testing new drugs.
- Identification of biologics and small molecules with potential efficacy.
Conclusions:
- Novel targeted therapies are emerging for eosinophilic disorders.
- These new agents offer alternatives to current treatments with potentially lower toxicity.
More Related Videos
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...